Morgan Stanley is out with its report today on Dr. Pepper Snapple Group DPS, initiating DPS at Equal-weight.
In its report, Morgan Stanley writes, "We initiate coverage of DPS at EW. Valuation looks undemanding at 8.2x 2012e EV/EBITDA, but appropriately discounts leverage to slower growth developed markets and mature beverage categories. Our top-line growth forecast is at the low end of DPS's 3-5% long-term target. DPS trades at 8.2x 2012e EV/EBITDA, a premium to global bottlers but well below its branded
beverage peers, appropriately reflecting the company's muted growth prospects and lower ROIC."
Shares of DPS closed Tuesday at $36.42.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in